Home > Result Summaries: Compounds > Hepatitis B Vaccine, Recombinant > Result Summary for 208129/033

Result Summary for 208129/033

Result Summary

Protocol ID:	208129/033
Clinical Study ID:	208129/033, 208109/038
Official Title:	A study to compare the immunogenicity and safety of GSK Biologicals adjuvanted HBV vaccine to Engerix™-B, in a non-responder population ≥ 15 years of age, when administered intramuscularly, according to a 0, 1, 2, 12 month schedule
Phase:	phase 3
Study Indications or Diseases:	Hepatitis B Vaccine
Generic Name:	Hepatitis B Vaccine, Recombinant
Trade/Product Name:	Engerix-B
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Verstraeten T et al. (2008) Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine. 26(51):6630–6638.